Name: Optimizing Apheresis Starting Material Collections for Stem Cell Gene Therapy Manufacturing for Patients with Genetic Hemoglobinopathies (26EL-662)
Start: 2026-08-12T10:00:00-04:00
End: 2026-08-12T11:00:00-04:00
Location: Online

Cookie Preferences

Choose which categories you want to allow. Strictly necessary cookies are always active.

Strictly Necessary Required for the website to function. Cannot be disabled.

Analytics Help us understand how visitors use the site.

Marketing Used to deliver relevant ads and track campaigns.

Other Additional third-party services and integrations.

Optimizing Apheresis Starting Material Collections for Stem Cell Gene Therapy Manufacturing for Patients with Genetic Hemoglobinopathies (26EL-662)

Related Events

Addressing Common Nonconformances from AABB and How to Prevent Them (26EL-694)

Nitrosamine Compliance: Regulatory Requirements from Risk Assessments to Control Strategies

WIB Unlocked! A Guide for New and Future Members